Informational Only · Not Medical Advice · Consult a Dermatologist · Editorial Policy

Recovery and Pigment Safety in the 2026 Split-Face Acne Scar Trial: Sample Size and Evidence Limits for People With Skin of Color

Recovery was brief and mild in the 2026 split-face acne scar trial, with pigment risk low but real for Fitzpatrick types III-V. Only 24 people enrolled, so results cannot assure the same healing for all people with skin of color.

A split-face study puts one treatment on one cheek and a comparison on the other. This trial tested fractional microneedle radiofrequency plus transdermal poly-L-lactic acid against radiofrequency plus sterile water. It enrolled Asian patients with moderate-to-severe atrophic acne scars, meaning depressed scars that sit below surrounding skin.

Medical information disclaimer: This article is for general educational purposes only and does not provide medical advice, diagnosis, or treatment. Always consult a physician or other qualified health professional about symptoms, medications, tests, or treatment decisions.

Table of Contents

What did each side of the face receive?

One cheek received fractional microneedle radiofrequency with transdermal poly-L-lactic acid. The other cheek received the same radiofrequency energy with sterile water. Dermatology and Therapy reports this randomized double-blind design in the trial report.

The split-face approach controlled differences between people because each person served as their own comparison. It did not replicate full-face treatment in routine care. Outcomes were also not separated by individual atrophic scar subtype.

How did skin heal after treatment?

Mild postinflammatory hyperpigmentation occurred in 2 of 24 participants, or 8.3%, and cleared within one month. That pattern points to low but nonzero pigment risk in types III-V skin.

Other effects were mild, transient and self-limiting. They included brief redness after treatment and one acne flare, with both types resolving without lasting harm.

Why does 24 people limit confidence?

Twenty-four participants is a modest sample for a scar treatment used across diverse practices. The authors state this size may limit generalizability beyond the studied group.

Small trials also give unstable estimates of uncommon harms. The authors call for larger multicenter randomized trials with longer follow-up to validate these early results and refine treatment settings.

What should people with skin of color discuss before booking?

People with darker skin tones face higher risk of dark spots and thickened scars after acne heals. The American Academy of Dermatology advises careful treatment and avoiding picking or squeezing lesions in skin-of-color acne guidance.

Radiofrequency microneedling carries additional procedural risks outside trials. The FDA warned on Oct. 15, 2025 about reports of burns, scarring, fat loss, nerve damage and disfigurement in the FDA safety communication.

  • Ask who will operate the device, what training they have, and what settings suit your skin tone
  • Ask how they track pigment change, redness, breakouts, burns, and nerve symptoms
  • Ask what aftercare, sun protection, and follow-up visits they provide
  • Do not pick or squeeze active breakouts before or after the procedure

You Might Also Like

We use cookies to run this site, measure how it’s used, and show ads. Choose “Essentials only” to limit cookies to what the site needs to work. Privacy Policy.